ChengDa Pharmaceuticals Co. Ltd. (301201) — Cash Flow Quality Index
ChengDa Pharmaceuticals Co. Ltd. (301201) has a Cash Flow Quality Index of 2.11x as of December 2023. Operating cash flow of CN¥192.07 Million exceeds net income of CN¥90.98 Million, indicating high earnings quality where cash backs reported profits. Also explore 301201 total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ChengDa Pharmaceuticals Co. Ltd. Cash Flow Quality Index (2019–2023)
Historical Cash Flow Quality Index for ChengDa Pharmaceuticals Co. Ltd. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of ChengDa Pharmaceuticals Co. Ltd. to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for ChengDa Pharmaceuticals Co. Ltd. (2019–2023)
Year-by-year earnings quality comparison for ChengDa Pharmaceuticals Co. Ltd.. For live market cap and the full company financial profile, see market value of ChengDa Pharmaceuticals Co. Ltd..
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 2.11x | CN¥192.07 Million | CN¥90.98 Million | ▲ +371.6% |
| 2022 | 0.45x | CN¥47.67 Million | CN¥106.48 Million | ▼ -45.9% |
| 2021 | 0.83x | CN¥83.14 Million | CN¥100.44 Million | ▼ -22.2% |
| 2020 | 1.06x | CN¥128.97 Million | CN¥121.17 Million | ▼ -14.5% |
| 2019 | 1.25x | CN¥67.52 Million | CN¥54.22 Million | — |